Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ravuconazole (ER-30346) 是一种口服的三唑广谱抗真菌剂。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 233 | 现货 | ||
2 mg | ¥ 328 | 现货 | ||
5 mg | ¥ 496 | 现货 | ||
10 mg | ¥ 745 | 现货 | ||
25 mg | ¥ 1,820 | 现货 | ||
50 mg | ¥ 2,820 | 现货 | ||
100 mg | ¥ 3,970 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 546 | 现货 |
产品描述 | Ravuconazole (ER-30346) is a potent triazole antifungal that potently inhibits a wide range of fungi. |
体外活性 | The in vitro activity of BMS-207147 against 80 clinical isolates of Aspergillus was compared with that of itraconazole and amphotericin B, using a validated microtiter method.?Geometric mean MICs (in microg/ml) were as follows: 1.71 for BMS-207147, 0.67 for itraconazole, and 0.63 for amphotericin B. The range of concentrations of each drug was 0.125 to >16 microg/ml.?Aspergillus fumigatus was significantly more susceptible to BMS-207147 (P < 0.?05) than A. terreus and A. flavus.?No BMS-207147-resistant A. fumigatus isolates were identified, though eight itraconazole-resistant (MIC, >8 microg/ml) isolates were.?BMS-207147 is active against Aspergillus spp. at slightly high concentrations compared with itraconazole and amphotericin B[1]. |
别名 | 立福康唑, 雷夫康唑, BMS-207147, ER-30346 |
分子量 | 437.47 |
分子式 | C22H17F2N5OS |
CAS No. | 182760-06-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (114.29 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.2859 mL | 11.4294 mL | 22.8587 mL | 57.1468 mL |
5 mM | 0.4572 mL | 2.2859 mL | 4.5717 mL | 11.4294 mL | |
10 mM | 0.2286 mL | 1.1429 mL | 2.2859 mL | 5.7147 mL | |
20 mM | 0.1143 mL | 0.5715 mL | 1.1429 mL | 2.8573 mL | |
50 mM | 0.0457 mL | 0.2286 mL | 0.4572 mL | 1.1429 mL | |
100 mM | 0.0229 mL | 0.1143 mL | 0.2286 mL | 0.5715 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Ravuconazole 182760-06-1 Microbiology/Virology Antifungal ER 30346 inhibit ER30346 BMS207147 立福康唑 Fungal Inhibitor 雷夫康唑 BMS 207147 BMS-207147 ER-30346 inhibitor